Skip over main navigation
  • Log in
  • Basket: (0 items)
Emerge Australia
  • Twitter
  • Facebook
  • Email
Donate Become a member
Menu
  • About us
    • What we do
    • Our team
    • Our Ambassador
    • Our impact
    • Annual reports
    • Position Statements
    • Contact us
  • ME/CFS information
    • ME/CFS Information
    • Long COVID
    • Post-Exertional Malaise
    • Management
    • For health professionals
    • For carers
    • Member stories
  • Research
    • OMF Australia
    • ME/CFS biobank and registry
    • Research Digest
    • Health and Wellbeing Survey
  • How to get help
    • Patient Support and Information Services
    • Telehealth Nurse Service
    • Online Community
    • GP Education Program
    • Accessing financial support
      • About NDIS
      • About DSP
      • NDIS and DSP Application Resources
  • Get involved
    • Give monthly
    • Donate
    • Fundraisers
    • Bequest giving
    • Emerge Australia Membership
    • Volunteer with us
    • Patient Advisory Group
    • Campaigns and advocacy resources
    • ME/CFS Awareness Week
  • Forum
  • News
  • Admin
    • Log in
  • Basket: (0 items)
  • Open Medicine Foundation Australia
  1. Research
  2. OMF Australia

Open Medicine Foundation Australia

Established in October 2020, Open Medicine Foundation Australia (OMF Australia) is an Australian foundation set up to support biomedical research through the establishment of a new ME/CFS research collaboration in Australia. OMF Australia was founded by Emerge Australia in partnership with the Open Medicine Foundation, meaning that Australia is now part of the largest, concerted worldwide non-profit effort to diagnose, treat and find a cure for ME/CFS.

The Australian collaboration is directed by Christopher Armstrong, PhD, and seeks to develop a disease management and treatment approach that focuses on the individual patient and the biology that underlies their disease. The research will look for unifying biological pathways of ME/CFS that cause the disease experience to be the same between patients, while also identifying biological aspects that produce different disease experiences between patients.

"I am thrilled that OMF has decided to expand its global ME/CFS research network to Australia,” Dr Armstrong said. “This will be the fifth research collaboration of this network and I am absolutely honoured to be the director.

"Over the past couple years I have been working with the other CRC directors, observing the great research at Stanford, Harvard, Uppsala and Montreal and I'm excited to bring the excellent Australian research community to the fold."

Dr Chris Armstrong

Chris Armstrong, PhD, is OMF’s former Science Liaison and Visiting Scholar at Stanford University and has been involved with researching ME/CFS for more than a decade. An Australian native, he is perfectly positioned to lead and grow this new research hub for years to come.

Dr Armstrong is most well-known for his research using metabolomics to observe biochemical alterations in ME/CFS patients. He began his work in this field at the University of Melbourne, completing his PhD in applying metabolomics to study ME/CFS. He published his first ME/CFS metabolomics study on blood and urine in 2015.

Since then he has set up collaborative efforts to apply metabolomics to immunological experiments on ME/CFS, observing how metabolism may relate to immune cell function. He has also focused on longitudinal research while looking to extend metabolic capabilities across the field of ME/CFS to help collate different patient groups.

Under Dr Armstrong’s direction, the team at OMFA will conduct a ground-breaking research program to develop a personalised medicine approach for studying and treating ME/CFS.

In its first project his team will deeply characterise the biology of people with ME/CFS by continuously monitoring their health data and sporadically sampling and analysing their blood and urine over the course of a year. Data will be analysed to identify characteristics of disease severity in individuals, then compared across patients to identify patterns – helping to reduce the complexity and length of the personalised medicine approach.

The expected outcome is the establishment of a condensed personalised research method that can be used to track the development of ME/CFS, provide an understanding of the biology of the disease process in the individual, and monitor outcomes in treatment trials.

Published: 21st October, 2020

Updated: 21st March, 2022

Author: Paula Gething

Share this page
  • Email
  • Facebook
  • Twitter

Latest

  • Building your Post-Exertional Malaise (PEM) Toolkit

    Building your Post-Exertional Malaise (PEM) Toolkit

    Join Emerge Australia's Manager of Patient Support and Information Services Laura Allen and Nurse Educator Kate Herbert in an interactive session to support you in building your post-exertional malaise (PEM) toolkit! This powerful session pools the collective wisdom of our amazing ME/CFS community to support you to come away with new tools to manage PEM.

  • Emerge Australia Ambassador Bloom - Fundraising page

    Emerge Australia Ambassador Bloom - Fundraising page

    We are so proud to announce our new ambassadorship with recording artist Amanda Canzurlo, who uses the stage name of Bloom. Bloom has teamed up with Emerge Australia to help raise vital funds and awareness for ME/CFS and our work to support the 250,000 Australians living with the disease.

  • Political Parties Missing 'The Forgotten Community' With COVID as Patient Numbers Forecast to Double

    Political Parties Missing 'The Forgotten Community' With COVID as Patient Numbers Forecast to Double

    Emerge Australia has urged Political Parties and Candidates standing in the Federal Election to increase their knowledge and understanding of myalgic encephalomyelitis/chronic fatigue syndrome (ME/CFS).

  • National Volunteer Week 2022

    National Volunteer Week 2022

    Thank you to our amazing volunteers who contribute their support to the ME/CFS community through our services and programs.

Related

  • #MEAction Network

    A global, grassroots network for people with Myalgic Encephalomyelitis and Chronic Fatigue Syndrome

  • International Alliance for ME

    International Alliance for ME

    The International Alliance for ME is a collaboration of ME organisations across the world

Most read

  • What is ME/CFS?

    What is ME/CFS?

    Myalgic encephalomyelitis/chronic fatigue syndrome (ME/CFS) is a complex and disabling disease that affects many parts of the body, including the brain and muscles, as well as the digestive, immune and cardiac systems, among others.

  • Patient Support and Information Services

    Patient Support and Information Services

    Emerge Australia provides an information line where you can find out about the latest news and information about ME/CFS.

  • What we do

    What we do

    Who we are and what we do

  • Volunteer with us

    Volunteer with us

    Join our small, friendly and enthusiastic team as a volunteer

  • How is functional impairment assessed?

  • Coronavirus and ME - Simplified facts

    Coronavirus and ME - Simplified facts

    Many people with ME/CFS and other vulnerable communities in Australia are concerned about the impacts of the spreading coronavirus disease COVID-19. This is an easy-read resource with the latest information and advice.

  • Annual reports

    Annual reports for Emerge Australia

  • Symposium

    Replace this with your content

  • Patient Advisory Group

    Patient Advisory Group

    The Patient Advisory Group provides Emerge Australia with ongoing advice about the needs of the community, as well as invaluable input into projects

  • Terms and conditions

Sign up to our newsletter

* indicates required


Specific mailing lists

Helpful links

  • Sitemap
  • Accessibility
  • Terms & Conditions
  • Privacy Policy

Connect with us

  • Twitter
  • Facebook
  • YouTube


Get in touch with us

Emerge Australia
Level 7, 276 Flinders Street
Melbourne VIC 3000
1800 865 321
03 9529 1344
Media enquiries:
Ron Smith 0417 329 201 

 

Emerge Australia is registered as a charity with the Australian Charities and Not-for-profits Commission (ACNC). We are authorised by the Australian Tax Office as a deductible gift recipient (DGR). 

ABN/DGR: 22 385 438 041

Donations of $2 or more are tax-deductible. 

Emerge Australia acknowledges Aboriginal and Torres Strait Islander people as the Traditional Custodians of the land and pays respect to their Elders past and present.

© 2019 Emerge Australia. All rights reserved.